-
-
-
-
-
-
-
Ascendis Pharma to Report Full Year 2025 Financial Results and Provide Business Update on February 11, 2026
-
-
-
-
-
-
-
Ascendis Pharma to Report Third Quarter 2025 Financial Results and Provide Business Update on November 12, 2025
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Hold Rating on Ascendis Pharma (ASND)
-
-
-
-
-
-
-
Biotech Q4 earnings preview: Goldman Sachs
-
-
-
-
-
-
-
Ascendis Pharma to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
-
-
-
-
-
-
-
Ascendis Pharma Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
-
1,198,724 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

